Drug Trial Radar · NCT06885281
A Study of ZL-1310 in Participants With Selected Solid Tumors
Last checked: Nov 20, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
166
Planned (sponsor's estimate)
Start
May 12, 2025
Primary completion
Aug 2027
Study completion Apr 2028
Sponsor
- Lead sponsor
- Zai Lab (Shanghai) Co., Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- Zai Lab (US) LLC
- First posted
- Mar 20, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors
Conditions
- Solid Tumors
Interventions
ZL-1310Drug
drug ZL-1310
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment Emergent Adverse-Events in Phase 1bTime frame: up to 36 months
- Incidence of Serious Adverse Events in Phase 1bTime frame: up to 36 months
- Evaluate antitumor activity of ZL-1310 as a single agent in Phase 2Time frame: up to 36 months
Locations
23 sites in 2 countries. Site status is shown where the registry gives one.
University of California San Francisco/Helen Diller Family Comprehensive Cancer Center
San Francisco, California · Recruiting
OSF St. Francis Medical Center
Peoria, Illinois · Recruiting
Karmanos Cancer Center
Detroit, Michigan · Recruiting
Memorial Sloan-Kettering Cancer Center
New York, New York · Recruiting
University Hospitals Cleveland Medical Center
Cleveland, Ohio · Recruiting
Fox Chase Cancer Center
Philadelphia, Pennsylvania · Recruiting
SCRI OP (Oncology Partners)
Nashville, Tennessee · Recruiting
Texas Oncology / Sammons Cancer Center
Dallas, Texas · Recruiting
The University of Texas M. D. Anderson Cancer Center
Houston, Texas · Recruiting
Texas Oncology - Central South
McAllen, Texas · Recruiting
Virginia Cancer Specialists
Fairfax, Virginia · Recruiting
Virginia Oncology Associates
Norfolk, Virginia · Recruiting
Beijing Cancer Hospital
Beijing, Beijing Municipality, China · Recruiting
Beijing Gobroad Hospital
Beijing, Beijing Municipality, China · Recruiting
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China · Recruiting
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China · Recruiting
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China · Recruiting
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China · Recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Recruiting
Jilin Cancer Hospital
Changchun, Jilin, China · Recruiting
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China · Recruiting
Huashan Hospital Fudan University
Shanghai, Shanghai Municipality, China · Recruiting
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.